These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
365 related articles for article (PubMed ID: 22072239)
61. Utility of PET/CT in the diagnosis and staging of extranodal natural killer/T-cell lymphoma: a systematic review and meta-analysis. Zhou X; Lu K; Geng L; Li X; Jiang Y; Wang X Medicine (Baltimore); 2014 Dec; 93(28):e258. PubMed ID: 25526450 [TBL] [Abstract][Full Text] [Related]
62. Diagnostic accuracy of Kim SJ; Lee SW; Pak K; Kim IJ; Kim K Br J Radiol; 2018 Jun; 91(1086):20170520. PubMed ID: 29327944 [TBL] [Abstract][Full Text] [Related]
64. Diagnostic value of using 18F-FDG PET and PET/CT in immunocompetent patients with primary central nervous system lymphoma: A systematic review and meta-analysis. Zou Y; Tong J; Leng H; Jiang J; Pan M; Chen Z Oncotarget; 2017 Jun; 8(25):41518-41528. PubMed ID: 28514747 [TBL] [Abstract][Full Text] [Related]
65. Detection of distant interval metastases after neoadjuvant therapy for esophageal cancer with 18F-FDG PET(/CT): a systematic review and meta-analysis. Kroese TE; Goense L; van Hillegersberg R; de Keizer B; Mook S; Ruurda JP; van Rossum PSN Dis Esophagus; 2018 Dec; 31(12):. PubMed ID: 29917073 [TBL] [Abstract][Full Text] [Related]
66. Diagnostic accuracy of 18F-FDG PET/CT for detecting recurrence in patients with primary skeletal Ewing sarcoma. Sharma P; Khangembam BC; Suman KC; Singh H; Rastogi S; Khan SA; Bakhshi S; Thulkar S; Bal C; Malhotra A; Kumar R Eur J Nucl Med Mol Imaging; 2013 Jul; 40(7):1036-43. PubMed ID: 23558689 [TBL] [Abstract][Full Text] [Related]
67. Diagnostic Performance of F-18 Fluorodeoxyglucose Positron Emission Tomography or Positron Emission Tomography/Computed Tomography for Differentiation of Benign and Malignant Vertebral Compression Fractures: A Meta-Analysis. Kim SJ; Lee JS World Neurosurg; 2020 May; 137():e626-e633. PubMed ID: 32105873 [TBL] [Abstract][Full Text] [Related]
68. Diagnostic value of [18F] FDG-PET and PET/CT in urinary bladder cancer: a meta-analysis. Zhang H; Xing W; Kang Q; Chen C; Wang L; Lu J Tumour Biol; 2015 May; 36(5):3209-14. PubMed ID: 25809703 [TBL] [Abstract][Full Text] [Related]
69. Is combined 18F-fluorodeoxyglucose-positron emission tomography/computed tomography superior to positron emission tomography or computed tomography alone for diagnosis, staging and restaging of pancreatic lesions? Casneuf V; Delrue L; Kelles A; Van Damme N; Van Huysse J; Berrevoet F; De Vos M; Duyck P; Peeters M Acta Gastroenterol Belg; 2007; 70(4):331-8. PubMed ID: 18330088 [TBL] [Abstract][Full Text] [Related]
70. Diagnostic test accuracies of F-18 FDG PET/CT for prediction of microvascular invasion of hepatocellular carcinoma: A meta-analysis. Kim K; Kim SJ Clin Imaging; 2021 Nov; 79():251-258. PubMed ID: 34157501 [TBL] [Abstract][Full Text] [Related]
71. Response to Early Treatment Evaluated with 18F-FDG PET and PERCIST 1.0 Predicts Survival in Patients with Ewing Sarcoma Family of Tumors Treated with a Monoclonal Antibody to the Insulinlike Growth Factor 1 Receptor. Hyun O J; Luber BS; Leal JP; Wang H; Bolejack V; Schuetze SM; Schwartz LH; Helman LJ; Reinke D; Baker LH; Wahl RL J Nucl Med; 2016 May; 57(5):735-40. PubMed ID: 26795289 [TBL] [Abstract][Full Text] [Related]
72. Diagnostic accuracy of F-18 FDG PET/CT for characterization of colorectal focal FDG uptake: a systematic review and meta-analysis. Son GM; Kim SJ Abdom Radiol (NY); 2019 Feb; 44(2):456-463. PubMed ID: 30132094 [TBL] [Abstract][Full Text] [Related]
74. The impact of Elmanzalawy A; Vali R; Chavhan GB; Gupta AA; Omarkhail Y; Amirabadi A; Shammas A Pediatr Radiol; 2020 Feb; 50(2):252-260. PubMed ID: 31628508 [TBL] [Abstract][Full Text] [Related]
75. Staging of newly diagnosed Ewing sarcoma: Results of bone marrow aspiration and biopsy versus (18)FDG-PET/CT imaging for bone marrow involvement. Guinot A; Tabone-Eglinger S; Isnardi V; Bahri H; Surdez D; Delattre O; Pierron G; Villemeur M; Lapouble E; Brahmi M; Bouhamama A; Corradini N; Marec-Bérard P Eur J Cancer; 2023 Jan; 179():56-64. PubMed ID: 36502618 [TBL] [Abstract][Full Text] [Related]
76. Comparison of choline-PET/CT, MRI, SPECT, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: a meta-analysis. Shen G; Deng H; Hu S; Jia Z Skeletal Radiol; 2014 Nov; 43(11):1503-13. PubMed ID: 24841276 [TBL] [Abstract][Full Text] [Related]
77. Diagnostic Yield of Body CT and Whole-Body FDG PET/CT for Initial Systemic Staging in Patients With Suspected Primary CNS Lymphoma: A Systematic Review and Meta-Analysis. Park HY; Suh CH; Huang RY; Guenette JP; Kim HS AJR Am J Roentgenol; 2021 May; 216(5):1172-1182. PubMed ID: 32812800 [No Abstract] [Full Text] [Related]
78. Performance of pre-treatment ¹⁸F-fluorodeoxyglucose positron emission tomography/computed tomography for detecting metastasis in ovarian cancer: a systematic review and meta-analysis. Han S; Woo S; Suh CH; Lee JJ J Gynecol Oncol; 2018 Nov; 29(6):e98. PubMed ID: 30207106 [TBL] [Abstract][Full Text] [Related]
79. The role of 18F-FDG-PET and PET/CT in patients with sarcoidosis: an updated evidence-based review. Treglia G; Annunziata S; Sobic-Saranovic D; Bertagna F; Caldarella C; Giovanella L Acad Radiol; 2014 May; 21(5):675-84. PubMed ID: 24703482 [TBL] [Abstract][Full Text] [Related]